Cox Karen Sue
Known title: President, Chamberlain Univ.CIK: 0001752237
Associated companies
Transaction History
| CVSA | ▼ Sell | Open Market | 2,000 | $249K | 5/8/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 310 | $30K | 11/13/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 581 | $56K | 11/12/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 282 | $38K | 8/25/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 662 | $89K | 8/24/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 9,152 | $1.2M | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 4,033 | $544K | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 4,498 | $607K | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 636 | $86K | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 10,239 | $1.4M | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 2,110 | $190K | 11/13/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 391 | $30K | 8/26/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 557 | $42K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 282 | $21K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 721 | $54K | 8/25/2024 | View on chart |
| CVSA | ▲ Buy | Grant | 1,260 | $95K | 8/25/2024 | View on chart |
| CVSA | ▲ Buy | Grant | 1,631 | $123K | 8/25/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 666 | $50K | 8/24/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 625 | $47K | 8/23/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 218 | $9K | 8/28/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 260 | $11K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 1,430 | $62K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 413 | $18K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 1,529 | $66K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 435 | $19K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 182 | $8K | 8/25/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 435 | $19K | 8/24/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 4,330 | $186K | 8/23/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 390 | $16K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 215 | $9K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 217 | $9K | 8/28/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 754 | $30K | 8/28/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 1,355 | $54K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 179 | $7K | 8/27/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 255 | $10K | 8/26/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 184 | $8K | 8/25/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 4,590 | $182K | 8/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.